Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.

Yang P, Liang M, Zhang Y, Shen B.

Adv Ther. 2008 Aug;25(8):787-94. doi: 10.1007/s12325-008-0079-x.

PMID:
18670743
2.

Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.

Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM.

Eur J Surg Oncol. 2005 May;31(4):331-47. Review.

PMID:
15837037
3.

Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.

Mahnken AH, Bruners P, Günther RW.

Dig Dis. 2009;27(2):148-56. doi: 10.1159/000218347. Epub 2009 Jun 22. Review.

PMID:
19546553
5.

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.

Lan T, Chang L, Rahmathullah MN, Wu L, Yuan YF.

Medicine (Baltimore). 2016 Apr;95(15):e3185. doi: 10.1097/MD.0000000000003185. Review.

6.

Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes.

Ahrar K, Gupta S.

Surg Oncol Clin N Am. 2003 Jan;12(1):105-26. Review.

PMID:
12735133
7.

Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.

Maleux G, van Malenstein H, Vandecaveye V, Heye S, Vaninbroukx J, Nevens F, Verslype C.

Dig Dis. 2009;27(2):157-63. doi: 10.1159/000218348. Epub 2009 Jun 22. Review.

PMID:
19546554
8.

Treatment outcomes of transcatheter arterial chemoembolization combined with local ablative therapy versus monotherapy in hepatocellular carcinoma: a meta-analysis.

Gu L, Liu H, Fan L, Lv Y, Cui Z, Luo Y, Liu Y, Li G, Li C, Ma J.

J Cancer Res Clin Oncol. 2014 Feb;140(2):199-210. Review.

PMID:
24077865
9.

Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literature.

Fouad M, Abdel-Rahman O.

Arab J Gastroenterol. 2015 Jun;16(2):40-5. doi: 10.1016/j.ajg.2015.03.003. Epub 2015 Apr 22. Review.

PMID:
25910573
10.

[Current therapy of hepatocellular carcinoma with special consideration of new and multimodal treatment concepts].

Göbel T, Blondin D, Kolligs F, Bölke E, Erhardt A.

Dtsch Med Wochenschr. 2013 Jul;138(27):1425-30. doi: 10.1055/s-0033-1343232. Epub 2013 Jun 25. Review. German.

PMID:
23801265
11.

Radiofrequency ablation for hepatocellular carcinoma.

Nishikawa H, Kimura T, Kita R, Osaki Y.

Int J Hyperthermia. 2013 Sep;29(6):558-68. doi: 10.3109/02656736.2013.821528. Epub 2013 Aug 12. Review.

PMID:
23937321
12.

Interventional treatments for hepatocellular carcinoma.

Guan YS, Liu Y.

Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):495-500. Review.

13.

Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Meng MB, Cui YL, Lu Y, She B, Chen Y, Guan YS, Zhang RM.

Radiother Oncol. 2009 Aug;92(2):184-94. doi: 10.1016/j.radonc.2008.11.002. Epub 2008 Nov 29. Review.

PMID:
19042048
14.

[Treatment of hepatocellular carcinoma].

Greten TF, Blum HE, Manns MP, Geissler M.

Z Gastroenterol. 2006 Jan;44(1):43-9. Review. German.

PMID:
16397839
15.

Hepatocellular carcinoma in viral hepatitis: improving standard therapy.

Masuzaki R, Yoshida H, Tateishi R, Shiina S, Omata M.

Best Pract Res Clin Gastroenterol. 2008;22(6):1137-51. doi: 10.1016/j.bpg.2008.11.005. Review.

PMID:
19187872
16.

Hepatocellular carcinoma: current management and recent advances.

Lau WY, Lai EC.

Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):237-57. Review.

17.

Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors.

Gadaleta CD, Ranieri G.

Crit Rev Oncol Hematol. 2011 Oct;80(1):40-53. doi: 10.1016/j.critrevonc.2010.10.005. Epub 2010 Nov 9. Review.

PMID:
21067940
18.

Novel advancements in the management of hepatocellular carcinoma in 2008.

Llovet JM, Bruix J.

J Hepatol. 2008;48 Suppl 1:S20-37. doi: 10.1016/j.jhep.2008.01.022. Epub 2008 Feb 12. Review.

PMID:
18304676
19.

The use of lentinan for treating gastric cancer.

Ina K, Kataoka T, Ando T.

Anticancer Agents Med Chem. 2013 Jun;13(5):681-8. Review.

20.

Medicinal and therapeutic value of the shiitake mushroom.

Jong SC, Birmingham JM.

Adv Appl Microbiol. 1993;39:153-84. Review. No abstract available.

PMID:
8213304

Supplemental Content

Support Center